| MeSH term | MeSH ID | Detail |
|---|---|---|
| Cleidocranial Dysplasia | D002973 | 1 associated lipids |
| Prediabetic State | D011236 | 1 associated lipids |
| Intracranial Hemorrhage, Traumatic | D020198 | 1 associated lipids |
| Neoplastic Syndromes, Hereditary | D009386 | 1 associated lipids |
| Scleroderma, Limited | D045745 | 1 associated lipids |
| Rheumatic Fever | D012213 | 1 associated lipids |
| Chronic Periodontitis | D055113 | 1 associated lipids |
| Dental Pulp Exposure | D003789 | 1 associated lipids |
| Dental Occlusion, Traumatic | D003769 | 1 associated lipids |
| Vestibulocochlear Nerve Diseases | D000160 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Bastos MF et al. | Hypertension may affect tooth-supporting alveolar bone quality: a study in rats. | 2010 | J. Periodontol. | pmid:20350157 |
| Ohkido I et al. | The hypothesis that bone turnover influences FGF23 secretion. | 2010 | Kidney Int. | pmid:20354552 |
| Dai M et al. | [Expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin of mice osteoblast induced by metal ions]. | 2010 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:20369527 |
| Yu HC et al. | Mechanical stretching induces osteoprotegerin in differentiating C2C12 precursor cells through noncanonical Wnt pathways. | 2010 | J. Bone Miner. Res. | pmid:20200998 |
| Shan Y et al. | p38 MAPK plays a distinct role in sulforaphane-induced up-regulation of ARE-dependent enzymes and down-regulation of COX-2 in human bladder cancer cells. | 2010 | Oncol. Rep. | pmid:20204301 |
| Bao BY et al. | Clinical significance of tumor necrosis factor receptor superfamily member 11b polymorphism in prostate cancer. | 2010 | Ann. Surg. Oncol. | pmid:20204532 |
| Roshandel D et al. | Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men. | 2010 | J. Bone Miner. Res. | pmid:20205168 |
| Grauslund J et al. | Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes? | 2010 | Scand. J. Clin. Lab. Invest. | pmid:20205614 |
| Wang L et al. | Effects and mechanism of aromatic aminoketone SY0916 on osteoclastic bone destruction. | 2010 | Acta Pharmacol. Sin. | pmid:20208552 |
| Zagura M et al. | Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects. | 2010 | Am. J. Hypertens. | pmid:20224558 |
| Jurado S et al. | Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts. | 2010 | J. Cell. Biochem. | pmid:20225238 |
| Ma H et al. | Effects of diet-induced obesity and voluntary wheel running on bone properties in young male C57BL/6J mice. | 2010 | Calcif. Tissue Int. | pmid:20229059 |
| Jono S et al. | Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease. | 2010 | J. Thromb. Haemost. | pmid:20230427 |
| Chen CH et al. | Soluble receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation. | 2010 | Clin. Rheumatol. | pmid:20690034 |
| Røysland R et al. | Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial. | 2010 | Am. Heart J. | pmid:20691834 |
| Wiens M et al. | The role of biosilica in the osteoprotegerin/RANKL ratio in human osteoblast-like cells. | 2010 | Biomaterials | pmid:20673584 |
| Kadoglou NP et al. | Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. | 2010 | J. Vasc. Surg. | pmid:19837545 |
| Candido R et al. | Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. | 2010 | J. Vasc. Res. | pmid:19907187 |
| Nabipour I et al. | Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women. | 2010 | Metab. Clin. Exp. | pmid:19922962 |
| Barbagallo I et al. | Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. | 2010 | J. Bone Miner. Metab. | pmid:19924377 |
| Takács I et al. | Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression. | 2010 | Eur. J. Endocrinol. | pmid:19934266 |
| Liu YY et al. | Circulating Dickkopf-1 and osteoprotegerin in patients with early and longstanding rheumatoid arthritis. | 2010 | Chin. Med. J. | pmid:20819596 |
| Eriksen CG et al. | The expression of IL-6 by osteoblasts is increased in healthy elderly individuals: stimulated proliferation and differentiation are unaffected by age. | 2010 | Calcif. Tissue Int. | pmid:20820764 |
| Camozzi V et al. | Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome. | 2010 | Eur. J. Endocrinol. | pmid:19793762 |
| Bitto A et al. | Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques. | 2010 | J. Vasc. Surg. | pmid:20719466 |
| Caidahl K et al. | Osteoprotegerin: a biomarker with many faces. | 2010 | Arterioscler. Thromb. Vasc. Biol. | pmid:20720194 |
| Bergestuen DS et al. | Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis. | 2010 | Neuroendocrinology | pmid:20720391 |
| Rooney T et al. | Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade. | 2010 | Rheumatol. Int. | pmid:19847430 |
| Rutges JP et al. | Hypertrophic differentiation and calcification during intervertebral disc degeneration. | 2010 | Osteoarthr. Cartil. | pmid:20723612 |
| Pennisi P et al. | The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role? | 2010 | Maturitas | pmid:20727694 |
| Nezami N et al. | Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy. | 2010 | Clin. Biochem. | pmid:20727867 |
| Zhang Y et al. | Osteogenic properties of hydrophilic and hydrophobic titanium surfaces evaluated with osteoblast-like cells (MG63) in coculture with human umbilical vein endothelial cells (HUVEC). | 2010 | Dent Mater | pmid:20728208 |
| Chollet ME et al. | Evidence of a colocalisation of osteoprotegerin (OPG) with von Willebrand factor (VWF) in platelets and megakaryocytes alpha granules. Studies from normal and grey platelets. | 2010 | Br. J. Haematol. | pmid:19958354 |
| Lossdörfer S et al. | Anabolic effect of intermittent PTH(1-34) on the local microenvironment during the late phase of periodontal repair in a rat model of tooth root resorption. | 2010 | Clin Oral Investig | pmid:19280233 |
| Cianciolo G et al. | Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index? | 2010 | Blood Purif. | pmid:19816015 |
| Taveira AT et al. | Longitudinal evaluation of hepatic osteodystrophy in children and adolescents with chronic cholestatic liver disease. | 2010 | Braz. J. Med. Biol. Res. | pmid:21049245 |
| Pivonka P et al. | Theoretical investigation of the role of the RANK-RANKL-OPG system in bone remodeling. | 2010 | J. Theor. Biol. | pmid:19782692 |
| Singh DK et al. | Low serum osteoprotegerin levels in normoalbuminuric type 1 diabetes mellitus. | 2010 | Acta Diabetol | pmid:19784545 |
| Han G et al. | Effects of simvastatin on relapse and remodeling of periodontal tissues after tooth movement in rats. | 2010 | Am J Orthod Dentofacial Orthop | pmid:21055594 |
| Jung CH et al. | The relationship between coronary artery calcification score, plasma osteoprotegerin level and arterial stiffness in asymptomatic type 2 DM. | 2010 | Acta Diabetol | pmid:19787288 |
| Ta HM et al. | Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21059944 |
| Pi M et al. | Impaired osteoblast function in GPRC6A null mice. | 2010 | J. Bone Miner. Res. | pmid:19874200 |
| Riches PL and Ralston SH | Recent insights into the biology of bone turnover. | 2010 | J R Coll Physicians Edinb | pmid:21125043 |
| Secchiero P et al. | Baseline serum concentrations of TRAIL in early rheumatoid arthritis: relationship with response to disease-modifying antirheumatic drugs. | 2010 | J. Rheumatol. | pmid:20472926 |
| Scheres N et al. | Gingival and periodontal ligament fibroblasts differ in their inflammatory response to viable Porphyromonas gingivalis. | 2010 | J. Periodont. Res. | pmid:19778323 |
| Santos VR et al. | Receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in sites of chronic periodontitis of subjects with poorly and well-controlled type 2 diabetes. | 2010 | J. Periodontol. | pmid:20476881 |
| Chadipiralla K et al. | Osteogenic differentiation of stem cells derived from human periodontal ligaments and pulp of human exfoliated deciduous teeth. | 2010 | Cell Tissue Res. | pmid:20309582 |
| Zhang Y et al. | Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption. | 2010 | Br. J. Nutr. | pmid:20487580 |
| Sheng ZF et al. | OPG knockout mouse teeth display reduced alveolar bone mass and hypermineralization in enamel and dentin. | 2010 | Arch. Oral Biol. | pmid:20233613 |
| Castellino G et al. | The tumour necrosis factor-related apoptosis-inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? | 2010 | Rheumatology (Oxford) | pmid:20299382 |
| Son J et al. | cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20599715 |
| Horowitz MC et al. | How B cells influence bone biology in health and disease. | 2010 | Bone | pmid:20601290 |
| Nicolin V and Narducci P | Soluble TRAIL could enhance bone destruction acting on Rank-ligand in estrogen-independent human breast cancer cell line MDA-MB-231. | 2010 | Acta Histochem. | pmid:19058836 |
| Wasilewska A et al. | Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children. | 2010 | Pediatr. Nephrol. | pmid:20602239 |
| Chang IC et al. | Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. | 2010 | J Biomed Mater Res A | pmid:20623670 |
| Martin-Bautista E et al. | Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. | 2010 | Nutr Res | pmid:20579524 |
| Giorgetti AP et al. | Cigarette smoke inhalation modulates gene expression in sites of bone healing: a study in rats. | 2010 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:20573527 |
| Nybo M et al. | Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients. | 2010 | Diabet. Med. | pmid:20536491 |
| Zhang F et al. | Compressive force stimulates the gene expression of IL-17s and their receptors in MC3T3-E1 cells. | 2010 | Connect. Tissue Res. | pmid:20497006 |
| Quercioli A et al. | Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling. | 2010 | Eur. J. Clin. Invest. | pmid:20497460 |
| Shaker OG et al. | Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease. | 2010 | Angiology | pmid:20498140 |
| Dai J et al. | Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony-stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitors. | 2010 | Cancer Res. | pmid:20501834 |
| Kerr NM et al. | Ocular manifestations of juvenile Paget disease. | 2010 | Arch. Ophthalmol. | pmid:20547946 |
| Liu JM et al. | Analysis of recently identified osteoporosis susceptibility genes in Han Chinese women. | 2010 | J. Clin. Endocrinol. Metab. | pmid:20554715 |
| Aoki S et al. | Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesis. | 2010 | J. Bone Miner. Res. | pmid:20560139 |
| Byron CR et al. | In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells. | 2010 | Am. J. Vet. Res. | pmid:20513175 |
| Jilka RL et al. | Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms. | 2010 | J. Bone Miner. Res. | pmid:20533302 |
| Costa PP et al. | Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. | 2010 | J. Periodontol. | pmid:20192865 |
| Leung R et al. | Diffuse osteosclerosis complicating hairy cell leukemia. | 2010 | J. Clin. Oncol. | pmid:20194859 |
| Wang EB et al. | [Histochemical and immunohistochemical double staining for osteolytic related factors in keratocystic odontogenic tumor]. | 2010 | Beijing Da Xue Xue Bao | pmid:20140051 |
| Schlieper G et al. | Analysis of calcifications in patients with coral reef aorta. | 2010 | Ann Vasc Surg | pmid:20144533 |
| Ruckh TT et al. | Osteogenic differentiation of bone marrow stromal cells on poly(epsilon-caprolactone) nanofiber scaffolds. | 2010 | Acta Biomater | pmid:20144747 |
| Loncar G et al. | Relationship between RANKL and neuroendocrine activation in elderly males with heart failure. | 2010 | Endocrine | pmid:20963564 |
| Gibbons CL et al. | Osteoclast-like cells in soft tissue leiomyosarcomas. | 2010 | Virchows Arch. | pmid:20127110 |
| Enjuanes A et al. | The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts. | 2010 | Endocrine | pmid:20963568 |
| Mok SK et al. | Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. | 2010 | Br. J. Pharmacol. | pmid:20128811 |
| Vik A et al. | Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population--the Tromsø study. | 2010 | J. Thromb. Haemost. | pmid:20128863 |
| Hughes C et al. | Human single-chain variable fragment that specifically targets arthritic cartilage. | 2010 | Arthritis Rheum. | pmid:20131274 |
| Fei Q et al. | Osteogenic growth peptide enhances the proliferation of bone marrow mesenchymal stem cells from osteoprotegerin-deficient mice by CDK2/cyclin A. | 2010 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:20926513 |
| Makihira S et al. | Immobilized-OPG-Fc on a titanium surface inhibits RANKL-dependent osteoclast differentiation in vitro. | 2010 | J Mater Sci Mater Med | pmid:19834789 |
| Reinhard H et al. | Osteoprotegerin and mortality in type 2 diabetic patients. | 2010 | Diabetes Care | pmid:20929997 |
| Kadoglou NP et al. | Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis. | 2010 | Eur J Vasc Endovasc Surg | pmid:20004120 |
| Secchiero P et al. | An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction. | 2010 | Atherosclerosis | pmid:20015493 |
| Pal SN et al. | Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. | 2010 | Atherosclerosis | pmid:20004897 |
| Tomlins C and Storey A | Cutaneous HPV5 E6 causes increased expression of Osteoprotegerin and Interleukin 6 which contribute to evasion of UV-induced apoptosis. | 2010 | Carcinogenesis | pmid:20884685 |
| Rachner TD et al. | Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells. | 2010 | Cancer Lett. | pmid:19577359 |
| Bai Y et al. | Formation of bone-like tissue by dental follicle cells co-cultured with dental papilla cells. | 2010 | Cell Tissue Res. | pmid:20886237 |
| Wutzl A et al. | Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro. | 2010 | J. Orthop. Res. | pmid:20872578 |
| Wang J and Stern PH | Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA. | 2010 | J. Cell. Biochem. | pmid:20872746 |
| Kochetkova EA et al. | [Osteoprotegerin and bone mineral density in patients with chronic obstructive pulmonary disease]. | 2010 | Ter. Arkh. | pmid:20873238 |
| Yamano E et al. | Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis. | 2010 | Lab. Invest. | pmid:20421871 |
| Marini H et al. | Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study. | 2010 | Nutr Metab Cardiovasc Dis | pmid:19631515 |
| Trouvin AP and Goëb V | Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss. | 2010 | Clin Interv Aging | pmid:21228900 |
| Tan YY et al. | Effects of vascular endothelial growth factor (VEGF) on MC3T3-E1. | 2010 | Orthod Craniofac Res | pmid:21040465 |
| Gallo J et al. | [Synovial fluid from aseptically failed total hip or knee arthroplasty is not toxic to osteoblasts]. | 2010 | Acta Chir Orthop Traumatol Cech | pmid:21040654 |
| Salah H et al. | The clinical significance of OPG/sRANKL ratio in thalassemia patients suffering from osteopenia or osteoporosis in Egyptian patients. | 2010 | Immunol. Invest. | pmid:20718662 |
| Sun QF et al. | [Effects of high mobility group box 1 in activating periodontal ligament fibroblasts to express cytokine]. | 2010 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:20848944 |
| Hesse E et al. | Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. | 2010 | J. Cell Biol. | pmid:21173110 |
| Roato I et al. | Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase. | 2010 | PLoS ONE | pmid:21152388 |
| Zhou W et al. | [Effect of the compound of poly lactic-co-glycolic acid and bone marrow stromal cells modified by osteoprotegerin gene on the periodontal regeneration in Beagle dog periodontal defects]. | 2010 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:20635668 |